The NSW Cancer Council has today announced research grants to the value of $7 million, which will be used to curb cancer and look at new ways of treating it.
The Centenary Institute’s Associate Professor Jeff Holst will lead one of the key projects to be funded by these grants. The Centenary Institute has welcomed the kind generosity of the NSW Cancer Council and its recognition of Associate Professor Holst as one of Australia’s finest cancer researchers.
Associate Professor Jeff Holst, who leads the Centenary Institute’s Origins of Cancer Program, said this funding will help progress his research into the link between nutrition and cancer.
“My research has found that if we are able to block cancer cells from absorbing nutrients, we can essentially “starve” the cells and stop them from growing,” Associate Professor Holst said.
“We have already found this to be the case in prostate cancer, breast cancer and melanoma cells.
“This generous support from the NSW Cancer Council will enable my team and I to develop drugs aimed at effectively blocking the nutrient pumps which are feeding the cancer cells and allowing them to grow.”
The Centenary Institute also acknowledges the generosity of the Estate of the late Robyn Trinder, for its support in funding this research.
The Centenary Institute is currently working in collaboration with researchers at the University of Sydney and Eskitis Institute to advance this project.
Researchers have shown that older people and men tend to have higher levels of the enzyme ACE2 on the cells of their lower lungs–and that this may be the reason for their increased risk from COVID-19.
Scientists in Australia, including from the Centenary Institute, have developed a method for the rapid synthesis of safe vaccines.
Improving the clinical care of patients with cirrhosis will be the focus of a new three year PhD project being undertaken at the Centenary Institute.